Recounts the first decade of using the automatic implantable cardioverter defibrillator (AICD)
invented by Doctor Michel Mirowski. Characteristics of AICD patients; Impact of AICD on the …

Examines whether the 14-year evolution in technology and physician acceptance of
automatic implantable cardioverter defibrillator (AICD) technology have modified patient …

Careful evaluation of the efficacy and complications of implantable cardioverter defibrillators
(ICD) is important, as large numbers of these devices are being implanted at an accelerating …

During the last 25 years, remarkable technical and conceptual advances have occurred in
clinical electrophysiology. The scientific foundation that underpins the everyday use of the …

To evaluate the effectiveness of the automatic implantable cardioverter‐defibrillator (AICD),
a 7‐year experience, from 1983–1990, was reviewed. A total of 111 patients received an …

Ventricular arrhythmias remain a major cause of cardiovascular mortality. Therapy for
serious ventricular arrhythmias has evolved over the past decade, from treatment primarily …

In 1967, occasioned by the sudden death of a close colleague, Dr. Michel Mirowski
conceived the implantable defibrillator, someday resembling a pacemaker type implantation …

Objectives The primary objective of this trial is to determine whether implantation of AICD in
high risk coronary patients with potentially life-threatening ventricular arrhythmias will result …

Features the consensus statement issued by the North American Society of
Electrophysiology and Pacing, in conjunction with the American College of Cardiology …

The implantable cardioverter-defibrillator (ICD) has emerged as an effective, but expensive,
therapy for arrhythmic sudden cardiac death. ICD use has been increasing by 20% to 30 …